FI973185A0 - Use of melatonin in the treatment of patients with drug dependence - Google Patents
Use of melatonin in the treatment of patients with drug dependenceInfo
- Publication number
- FI973185A0 FI973185A0 FI973185A FI973185A FI973185A0 FI 973185 A0 FI973185 A0 FI 973185A0 FI 973185 A FI973185 A FI 973185A FI 973185 A FI973185 A FI 973185A FI 973185 A0 FI973185 A0 FI 973185A0
- Authority
- FI
- Finland
- Prior art keywords
- melatonin
- patients
- treatment
- drug dependence
- dependence
- Prior art date
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
- 229960003987 melatonin Drugs 0.000 title 1
- 208000011117 substance-related disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38153595 | 1995-02-01 | ||
| US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
| EP95303853 | 1995-06-06 | ||
| PCT/IB1996/000082 WO1996023496A1 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treating patients suffering from drug addiction |
| IB9600082 | 1996-01-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI973185A0 true FI973185A0 (en) | 1997-07-31 |
| FI973185L FI973185L (en) | 1997-09-30 |
| FI119586B FI119586B (en) | 2009-01-15 |
Family
ID=26140195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI973185A FI119586B (en) | 1995-02-01 | 1997-07-31 | Use of melatonin for the manufacture of a drug for the treatment of patients suffering from drug dependence |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JP4516159B2 (en) |
| CN (1) | CN1083263C (en) |
| AT (1) | AT408188B (en) |
| AU (1) | AU695366B2 (en) |
| BG (1) | BG62876B1 (en) |
| BR (1) | BR9607169A (en) |
| CZ (1) | CZ291349B6 (en) |
| DK (1) | DK176081B1 (en) |
| EE (1) | EE03384B1 (en) |
| FI (1) | FI119586B (en) |
| IS (1) | IS1980B (en) |
| LU (1) | LU90118B1 (en) |
| LV (1) | LV11940B (en) |
| MD (1) | MD1716C2 (en) |
| NO (1) | NO312814B1 (en) |
| NZ (1) | NZ298878A (en) |
| PL (1) | PL183148B1 (en) |
| SI (1) | SI9620022A (en) |
| SK (1) | SK284521B6 (en) |
| TR (1) | TR199700723T1 (en) |
| TW (1) | TW483757B (en) |
| WO (1) | WO1996023496A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227002B1 (en) | 2000-01-05 | 2010-04-28 | Neurim Pharma 1991 | Use of melatonin in the manufacture of controlled release medicament for the prevention or treatment of symptoms of hypertension |
| IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
| US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
| IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Composition for treating insomnia |
| PT2806863T (en) * | 2012-01-26 | 2017-11-09 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
| US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| EP3767297A1 (en) | 2012-12-18 | 2021-01-20 | Vanda Pharmaceuticals Inc. | Method of determining tau and thereby determining whether a patient has a free-running circadian rhythm |
| US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
| US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
| AU2016426598C1 (en) * | 2016-10-31 | 2024-02-08 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0518468T3 (en) * | 1991-05-09 | 2000-01-31 | Neurim Pharma 1991 | Melatonin-containing compositions |
| IT1251544B (en) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE |
-
1996
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2007001I2 (en) | MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES | |
| FI963696L (en) | Gel for the treatment of skin diseases and skin disinfection | |
| LV11615A (en) | Amid with medical treatment | |
| EE9800158A (en) | Epinastine for use in the treatment of pain | |
| FI953838L (en) | Imidazopyridines and their use in the treatment of gastrointestinal diseases | |
| LV10878A (en) | Treatment of the skin with selected amphiphilic copolymers | |
| FI963252A7 (en) | Novel opioid peptides for the treatment of pain and their use | |
| DE69310325D1 (en) | Patient treatment device with mattress and treatment chamber | |
| DK0668763T3 (en) | Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders | |
| NO975718L (en) | Treatment of insulin resistance | |
| FI973185A0 (en) | Use of melatonin in the treatment of patients with drug dependence | |
| PT932400E (en) | DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN | |
| FI941345A7 (en) | Retinoids and their use in the treatment of skin diseases and leukemia | |
| FI971527L (en) | Use of indole derivatives for the treatment of various diseases | |
| KR960702315A (en) | Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage | |
| FI974609A7 (en) | New heterocyclic compounds for the treatment of pain and their use | |
| ATA18093A (en) | HYPERTHERMAL TREATMENT CATHETER | |
| ID28817A (en) | USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT | |
| DE59811703D1 (en) | Medical or dental treatment chair | |
| FI972637A0 (en) | Use of vitamin K in the treatment of hyperthyroidism | |
| ITFI920241A0 (en) | USE OF MELATONIN IN THE THERAPY OF SYSTEMATIC SCLEROSIS, SARCOIDOSIS AND OTHERS | |
| YU40098A (en) | The use of olanzapine in preparation of medicine | |
| KR950008161U (en) | Personal poultice sauna | |
| KR980000770U (en) | Medical treatment device with desk | |
| KR950003086U (en) | Infrared Therapy for Medical Science |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 119586 Country of ref document: FI |
|
| MA | Patent expired |